Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis

Omar Galárraga, Burke Gao, Benson N Gakinya, Debra A Klein, Richard G Wamai, John E Sidle, Rebecca K Papas, Omar Galárraga, Burke Gao, Benson N Gakinya, Debra A Klein, Richard G Wamai, John E Sidle, Rebecca K Papas

Abstract

Background: Among HIV+ patients, alcohol use is a highly prevalent risk factor for both HIV transmission and poor adherence to HIV treatment. The large-scale implementation of effective interventions for treating alcohol problems remains a challenge in low-income countries with generalized HIV epidemics. It is essential to consider an intervention's cost-effectiveness in dollars-per-health-outcome, and the long-term economic impact -or "return on investment" in monetary terms.

Methods: We conducted a cost-benefit analysis, measuring economic return on investment, of a task-shifted cognitive-behavioral therapy (CBT) intervention delivered by paraprofessionals to reduce alcohol use in a modeled cohort of 13,440 outpatients in Kenya. In our base-case, we estimated the costs and economic benefits from a societal perspective across a six-year time horizon, with a 3% annual discount rate. Costs included all costs associated with training and administering task-shifted CBT therapy. Benefits included the economic impact of lowered HIV incidence as well as the improvements in household and labor-force productivity. We conducted univariate and multivariate probabilistic sensitivity analyses to test the robustness of our results.

Results: Under the base case, total costs for CBT rollout was $554,000, the value of benefits were $628,000, and the benefit-to-cost ratio was 1.13. Sensitivity analyses showed that under most assumptions, the benefit-to-cost ratio remained above unity indicating that the intervention was cost-saving (i.e., had positive return on investment). The duration of the treatment effect most effected the results in sensitivity analyses.

Conclusions: CBT can be effectively and economically task-shifted to paraprofessionals in Kenya. The intervention can generate not only reductions in morbidity and mortality, but also economic savings for the health system in the medium and long term. The findings have implications for other countries with generalized HIV epidemics, high prevalence of alcohol consumption, and shortages of mental health professionals.

Trial registration: This paper uses data derived from "Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans (KHBS)" with ClinicalTrials.gov registration NCT00792519 on 11/17/2008; and preliminary data from "A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention" ( NCT01503255 , registered on 12/16/2011).

Keywords: AIDS; Alcohol; CBT; Cognitive-behavioral-therapy; Cost-benefit-analysis; HIV; Kenya; Sub-Saharan Africa; Task-shifting.

Figures

Fig. 1
Fig. 1
Costs and potential benefits accrued (in time-discounted 2013 USD). Figure 1 illustrates the monetary costs and potential benefits from a cognitive behavioral therapy which would be used to reduce alcohol abuse among 13,440 persons living with HIV in Kenya. Values of cost and benefits were discounted at a rate of 3% assuming that they occur at the end of each year, thus costs in year 1 were not discounted
Fig. 2
Fig. 2
One-way sensitivity analyses for input variables that most affect the base case results. In the figure above, “Rise in labor force participation” is a measure of the percentage rise in weekly hours worked after ARV treatment; “Alcohol-attributable HIV incidence” is the percentage of HIV incidence attributable to alcohol consumption; “Rise in ARV-adherence” is the Increase in the likelihood that an HIV+ patient which moves from non-abstinence to abstinence behavior will be ARV-adherent; “Rise in abstinence due to CBT” is the Difference between intervention and usual care in percentage of patients reporting abstinence at 90 day follow-up; “Monthly Min Wage” is a measure of the Average Monthly Minimum Wage in Kenya in USD; “12 Month tenofovir/3TC/EFV” is the cost of a 12 Month tenofovir/3TC/EFV drug regimen expressed in 2013 USD; “Rise in hours collecting water” is the increase in female hours spent collecting water in past week; “Costs of CBT” is the cost of the CBT rollout per participant; “Rise in hours spent collecting firewood” is the increase in female hours spent collecting firewood in past week; “House worker min wage” is the Average Hourly Minimum Wage for House Worker. The numbers in the parentheses represent the upper and lower bounds of the sensitivity analysis. The numbers listed at the left and right hand side of the bars represent the benefit to cost ratio which would result from the target variable taking on the corresponding max or min value. Note that the vertical axis is at 1.13, but that all cost-benefit ratios above 1.0 are cost-saving and thus most variables maintain that CBT is cost saving across the entire range of variables. Ratios rounded to nearest hundredth. Abbreviations: BCR, benefit-to-cost ratio; CBT, cognitive behavioral therapy. The vertical axis intersects the horizontal axis at approximately 1.13
Fig. 3
Fig. 3
Distribution of benefit-to-cost ratios from Monte Carlo simulations. Figure 3 shows the results of our probabilistic sensitivity analysis with discounted net benefits. Separate sets of simulations were independently run for the assumption that program effect duration was 1, 2, 4, 5, or 10 years. Each set of simulations was made up of 10000 repetitions done across an independent sample of 13440 participants. Each set of simulations is also shown with a separate graph

References

    1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223–2233. doi: 10.1016/S0140-6736(09)60746-7.
    1. WHO . Global Status Report on Alcohol and Health 2014. Geneva: World Health Organization (WHO); 2014.
    1. Bass JK, Bornemann TH, Burkey M, Chehil S, Chen L, Copeland JR, Eaton WW, Ganju V, Hayward E, Hock RS, et al. A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has come. PLoS Med. 2012;9(1) doi: 10.1371/journal.pmed.1001159.
    1. Collins PY, Insel TR, Chockalingam A, Daar A, Maddox YT. Grand challenges in global mental health: integration in research, policy, and practice. PLoS Med. 2013;10(4) doi: 10.1371/journal.pmed.1001434.
    1. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Anderson W, Dhansay MA, Phillips A, Shurin S, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27–30. doi: 10.1038/475027a.
    1. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, Katabira E, Nachega JB. Depression, Alcohol Use and Adherence to Antiretroviral Therapy in Sub-Saharan Africa: A Systematic Review. AIDS Behav. 2012;16(8):2101–2118. doi: 10.1007/s10461-011-0087-8.
    1. Jaquet A, Ekouevi DK, Bashi J, Aboubakrine M, Messou E, Maiga M, Traore HA, Zannou MD, Guehi C, Ba-Gomis FO, et al. Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa. Addiction. 2010;105(8):1416–1421. doi: 10.1111/j.1360-0443.2010.02978.x.
    1. Scribner R, Theall KP, Simonsen N, Robinson W. HIV Risk and the Alcohol Environment Advancing an Ecological Epidemiology for HIV/AIDS. Alcohol Res Health. 2010;33(3):179–183.
    1. Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: Systematic review of empirical findings. Prev Sci. 2007;8(2):141–151. doi: 10.1007/s11121-006-0061-2.
    1. Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, Rodriguez MC, Rabeneck L, Bryant K, Justice AC. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459–466. doi: 10.1080/09540120601095734.
    1. Bryant KJ. Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS. Subst Use Misuse. 2006;41(10–12):1465–1507. doi: 10.1080/10826080600846250.
    1. WHO/UNAIDS/UNICEF . Progress report 2011: Global HIV/AIDS response. Epidemic update and health sector - progress towards Universal Access. Geneva: World Health Organization (WHO); 2011.
    1. UNAIDS . Report on the global AIDS epidemic 2012. Geneva: United National Joint Programme on HIV/AIDS (UNAIDS); 2012.
    1. UNAIDS . Getting to Zero: 2011-2015 Strategy. Geneva: United Nations Joint Programme on HIV/AIDS (UNAIDS); 2010.
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. doi: 10.1056/NEJMoa1105243.
    1. Karim SS, Karim QA. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet. 2011;378(9809):e23–e25. doi: 10.1016/S0140-6736(11)61136-7.
    1. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–245. doi: 10.1007/s10461-006-9078-6.
    1. Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41(3):385–392. doi: 10.1097/01.qai.0000186371.95301.52.
    1. Kalichman S, Simbayi L, Vermaak R, Cain D, Smith G, Mthebu J, Jooste S. Randomized Trial of a Community-based Alcohol-related HIV Risk-reduction Intervention for Men and Women in Cape Town South Africa. Ann Behav Med. 2008;36(3):270–279. doi: 10.1007/s12160-008-9067-2.
    1. Kalichman SC, Simbayi LC, Cain D, Jooste S. Alcohol expectancies and risky drinking among men and women at high-risk for HIV infection in Cape Town South Africa. Addict Behav. 2007;32(10):2304–2310. doi: 10.1016/j.addbeh.2007.01.026.
    1. Braithwaite RS, Bryant KJ. Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health. 2010;33(3):280–287.
    1. Gmel G, Shield KD, Rehm J. Developing a method to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol’s impact on adherence to antiretroviral medication. Popul Health Metrics. 2011;9(1):5. doi: 10.1186/1478-7954-9-5.
    1. Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–193. doi: 10.1016/j.drugalcdep.2010.06.014.
    1. Justice AC, Lasky E, McGinnis KA, Skanderson M, Conigliaro J, Fultz SL, Crothers K, Rabeneck L, Rodriguez-Barradas M, Weissman SB, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care. 2006;44(8 Suppl 2):S52–S60. doi: 10.1097/01.mlr.0000228003.08925.8c.
    1. Waweru M, Kamau A, Matogo J. Situational analysis of alcohol consumption among high school students: a baseline survey. SCAD: Nairobi; 2011.
    1. American Psychiatric Association., American Psychiatric Association. DSM-5 Task Force . Diagnostic and statistical manual of mental disorders : DSM-5. 5. Washington, D.C: American Psychiatric Association; 2013.
    1. Woolf-King SE, Maisto SA. Alcohol use and high-risk sexual behavior in Sub-Saharan Africa: a narrative review. Arch Sex Behav. 2011;40(1):17–42. doi: 10.1007/s10508-009-9516-4.
    1. Young SV, Wood E, Dong H, Kerr T, Hayashi K. Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Addiction. 2016;111(8):1360–5. doi: 10.1111/add.13256.
    1. WHO . mhGAP: Mental Health Gap Action Programme: scaling up care for mental, neurological and substance use disorders. Geneva: World Health Organization (WHO); 2008.
    1. Kiima D. Report of the World Mental Health Day held on 31st October 2008 at Mathari Hospital – Nairobi. Ministry of Health: Nairobi; 2008.
    1. KNCHR . The Silenced Minds: The Systemic Neglect of the Mental Health System in Kenya. Kenya National Commission on Human Rights: Nairobi; 2011.
    1. Kiima D, Jenkins R. Mental health policy in Kenya -an integrated approach to scaling up equitable care for poor populations. Int J Ment Health Sy. 2010;4.
    1. Obot IS. Alcohol use and related problems in sub-Saharan Africa. Afr J Drug Alcohol Stud. 2006;5(1):17–26.
    1. Baingana FK, Alem A, Jenkins R. Mental health and the abuse of alcohol and controlled substances. In: Jamison DT, Feachem RG, Makgoba MW, editors. Disease and mortality in Sub-Saharan Africa. 2. Washington, D.C: World Bank; 2006.
    1. Shaffer DN, Njeri R, Justice AC, Odero WW, Tierney WM. Alcohol abuse among patients with and without HIV infection attending public clinics in western Kenya. East Afr Med J. 2004;81:594–598.
    1. Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Mentor SM, Uhler LM, Roberts MS, Bryant K. Impact of Interventions Targeting Unhealthy Alcohol Use in Kenya on HIV Transmission and AIDS-Related Deaths. Alcohol Clin Exp Res. 2014;38(4):1059–1067. doi: 10.1111/acer.12332.
    1. Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Li L, Mentor SM, Uhler LM, Roberts MS, Galvani A, Bryant K. How Inexpensive Does an Alcohol Intervention in Kenya Need to be in Order to Deliver Favorable Value by Reducing HIV-Related Morbidity and Mortality? J Acquir Immune Defic Syndr. 2014;66(2):e54–e58.
    1. WHO . Task Shifting: Rational Redistribution of Tasks Among Health Workforce Teams: Global Recommendations and Guidelines. Geneva: World Health Organization (WHO); 2008.
    1. Frenk J, Chen L, Bhutta ZA, Cohen J, Crisp N, Evans T, Fineberg H, Garcia P, Ke Y, Kelley P, et al. Health professionals for a new century: transforming education to strengthen health systems in an interdependent world. Lancet. 2010;376(9756):1923–1958. doi: 10.1016/S0140-6736(10)61854-5.
    1. Callaghan M, Ford N, Schneider H. A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8. doi: 10.1186/1478-4491-8-8.
    1. Mdege ND, Chindove S, Ali S. The Effectiveness and Cost Implications of Task-Shifting in the Delivery of Antiretroviral Therapy to HIV-Infected Patients: A Systematic Review. Health Policy Plan. 2013;28(3):223–236. doi: 10.1093/heapol/czs058.
    1. Jenkins R, Kiima D, Njenga F, Okonji M, Kingora J, Kathuku D, Lock S. Integration of mental health into primary care in Kenya. World Psychiatry. 2010;9(2):118–120. doi: 10.1002/j.2051-5545.2010.tb00289.x.
    1. Mwandi Z, Murphy A, Reed J, Chesang K, Njeuhmeli E, Agot K, Llewellyn E, Kirui C, Serrem K, Abuya I, Loolpapit M, Mbayaki R, Kiriro N, Cherutich P, Muraguri N, Motoku J, Kioko J, Knight N, Bock N. Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008–2011. PLoS Med. 2011;8(11) doi: 10.1371/journal.pmed.1001130.
    1. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, Prozesky HW, Wiysonge CS, Mataya RH. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health. 2007;7:63. doi: 10.1186/1471-2458-7-63.
    1. Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, Yiannoutsos CT, Owiti M, Kimaiyo S, Braitstein P. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. B World Health Organ. 2010;88(9):681–688. doi: 10.2471/BLT.09.064329.
    1. Bryant KJ, Nelson S, Braithwaite RS, Roach D. Integrating HIV/AIDS and Alcohol Research. Alcohol Res Health. 2010;33(3):167–178.
    1. Papas RK, Sidle JE, Martino S, Baliddawa JB, Songole R, Omolo OE, Gakinya BN, Mwaniki MM, Adina JO, Nafula T, et al. Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav. 2010;14(3):669–678. doi: 10.1007/s10461-009-9647-6.
    1. Kadden RM, Cooney NL, Getter H, Litt MD. Matching alcoholics to coping skills or interactional therapies: posttreatment results. J Consult Clin Psychol. 1989;57(6):698–704. doi: 10.1037/0022-006X.57.6.698.
    1. Miller WR, Zweben J, Johnson WR. Evidence-based treatment: why, what, where, when, and how? J Subst Abus Treat. 2005;29(4):267–276. doi: 10.1016/j.jsat.2005.08.003.
    1. Jones DL, Ross D, Weiss SM, Bhat G, Chitalu N. Influence of partner participation on sexual risk behavior reduction among HIV-positive Zambian women. J Urban Health. 2005;82(3 Suppl 4):iv92–iv100.
    1. Osinowo HO, Olley BO, Adejumo AO. Evaluation of the effect of cognitive therapy on perioperative anxiety and depression among Nigerian surgical patients. West Afr J Med. 2003;22(4):338–342.
    1. Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Jama. 2006;295(17):2003–2017. doi: 10.1001/jama.295.17.2003.
    1. Lee JD, Grossman E, Huben L, Manseau M, McNeely J, Rotrosen J, Stevens D, Gourevitch MN. Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months. J Subst Abus Treat. 2012;43(4):458–462. doi: 10.1016/j.jsat.2012.08.012.
    1. Papas RK, Sidle JE, Gakinya BN, Baliddawa JB, Martino S, Mwaniki MM, Songole R, Omolo OE, Kamanda AM, Ayuku DO, et al. Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction. 2011;106(12):2156–2166. doi: 10.1111/j.1360-0443.2011.03518.x.
    1. Meyer-Rath G, Pienaar J, Brink B, van Zyl A, Muirhead D, Grant A, Churchyard G, Watts C, Vickerman P. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis. PLoS Med. 2015;12(9) doi: 10.1371/journal.pmed.1001869.
    1. Brent RJ. A social cost-benefit criterion for evaluating Voluntary Counseling and Testing with an application to Tanzania. Health Econ. 2010;19(2):154–172. doi: 10.1002/hec.1457.
    1. Owen L, Morgan A, Fischer A, Ellis S, Hoy A, Kelly MP. The cost-effectiveness of public health interventions. J Public Health (Oxf) 2012;34(1):37–45. doi: 10.1093/pubmed/fdr075.
    1. Drummond M, Drummond M. Methods for the economic evaluation of health care programmes. 3. Oxford; New York: Oxford University Press; 2005.
    1. Papas RK, Gakinya BN, Baliddawa JB, Martino S, Bryant KJ, Meslin EM, Sidle JE. Ethical issues in a stage 1 cognitive-behavioral therapy feasibility study and trial to reduce alcohol use among HIV-infected outpatients in western Kenya. J Empir Res Human Res Ethics. 2012;7(3):29–37. doi: 10.1525/jer.2012.7.3.29.
    1. Kenya National Bureau of Statistics. Consumer Price Index []. Accessed 20 Mar 2017.
    1. The World Bank . Official exchange rate (LCU per US$, period average) 2014.
    1. Hahn JA, Woolf-King SE, Muyindike W. Adding fuel to the fire: alcohol’s effect on the HIV epidemic in Sub-Saharan Africa. Curr HIV/AIDS Rep. 2011;8(3):172–180. doi: 10.1007/s11904-011-0088-2.
    1. Pithey A, Parry C. Descriptive systematic review of Sub-Saharan African studies on the association between alcohol use and HIV infection. SAHARA J. 2009;6(4):155–169. doi: 10.1080/17290376.2009.9724944.
    1. Van Tieu H, Koblin BA. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009;4(4):314–318. doi: 10.1097/COH.0b013e32832aa902.
    1. Woolf-King S, Steinmaus CM, Reingold AL, Hahn JA. An update on alcohol use and risk of HIV infection in sub-Saharan Africa: Meta-analysis and future research directions. Int J Alcohol Drug Res. 2013;2(1):99–110. doi: 10.7895/ijadr.v2i1.45.
    1. Larson BA, Bii M, Henly-Thomas S, McCoy K, Sawe F, Shaffer D, Rosen S. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics. J Int AIDS Soc. 2013;16:18026. doi: 10.7448/IAS.16.1.18026.
    1. WHO . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization (WHO); 2013.
    1. World Health Organization. Global Price Reporting Mechanism for HIV, tuberculosis and malaria []. Last accessed: 20 March 2017.
    1. Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–577. doi: 10.1097/01.ALC.0000122103.74491.78.
    1. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171–S176. doi: 10.1086/313849.
    1. Kekwaletswe CT, Morojele NK. Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus. Patient Prefer Adherence. 2014;8:401–413. doi: 10.2147/PPA.S55547.
    1. Enriquez M, McKinsey DS. Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level. HIV/AIDS (Auckland, NZ) 2011;3:45–51.
    1. Kader R, Govender R, Seedat S, Koch JR, Parry C. Understanding the Impact of Hazardous and Harmful Use of Alcohol and/or Other Drugs on ARV Adherence and Disease Progression. PLoS One. 2015;10(5) doi: 10.1371/journal.pone.0125088.
    1. Thirumurthy H, Zivin JG, Goldstein M. The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya. J Hum Resour. 2008;43(3):511–552. doi: 10.3368/jhr.43.3.511.
    1. Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galarraga O. Effect of antiretroviral therapy on patients’ economic well being: five-year follow-up. AIDS (London, England) 2014;28(3):417–424. doi: 10.1097/QAD.0000000000000053.
    1. Thirumurthy H, Zivin JG. Health and labor supply in the context of HIV/AIDS: the long-run economic impacts on antiretroviral therapy() Econ Dev Cult Chang. 2012;61(1):73–96. doi: 10.1086/666954.
    1. Venkataramani AS, Thirumurthy H, Haberer JE, Ii YB, Siedner MJ, Kembabazi A, Hunt PW, Martin JN, Bangsberg DR, Tsai AC. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS (London, England) 2014;28(8):1221–1226. doi: 10.1097/QAD.0000000000000188.
    1. d’Adda G, Goldstein M, Zivin JG, Nangami M, Thirumurthy H. ARV Treatment and Time Allocation to Household Tasks: Evidence from Kenya. Afr Dev Rev. 2009;21(1):180–208. doi: 10.1111/j.1467-8268.2009.00207.x.
    1. Cameron AC, Trivedi PK. Microeconometrics using Stata. College Station, Tex: Stata Press; 2010.
    1. Thirumurthy H, Galarraga O, Larson B, Rosen S. HIV treatment produces economic returns through increased work and education, and warrants continued US support. Health Aff (Millwood) 2012;31(7):1470–1477. doi: 10.1377/hlthaff.2012.0217.
    1. Parliament of Kenya . No 4 of 2010 (Rev) Kenya: National Council for Law Reporting with the Authority of the Attorney-General; 2012. Alcoholic Drinks Control Act.
    1. Litt MD, Kadden RM, Cooney NL, Kabela E. Coping skills and treatment outcomes in cognitive-behavioral and interactional group therapy for alcoholism. J Consult Clin Psychol. 2003;71(1):118–128. doi: 10.1037/0022-006X.71.1.118.
    1. Kadden RM, Litt MD, Cooney NL, Kabela E, Getter H. Prospective matching of alcoholic clients to cognitive-behavioral or interactional group therapy. J Stud Alcohol. 2001;62(3):359–369. doi: 10.15288/jsa.2001.62.359.
    1. Rappange DR, Brouwer WB, Rutten FF, van Baal PH. Lifestyle intervention: from cost savings to value for money. J Public Health (Oxf) 2010;32(3):440–447. doi: 10.1093/pubmed/fdp079.
    1. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. 2008;358(7):661–663. doi: 10.1056/NEJMp0708558.
    1. Braithwaite RS, Nucifora KA, Kessler J, Toohey C, Mentor SM, Uhler LM, Roberts MS, Bryant K. Impact of interventions targeting unhealthy alcohol use in Kenya on HIV transmission and AIDS-related deaths. Alcohol Clin Exp Res. 2014;38(4):1059–67. doi: 10.1111/acer.12332.
    1. Government of Kenya. The Regulation of Wages Order, 2013 [] Accessed 20 Mar 2017.

Source: PubMed

3
Předplatit